News Daily News Data Hint at Unintended Consequences of Hospital Readmissions Reduction Program L.A. McKeown December 21, 2018
News Daily News Thienopyridines May Help ID Migraine Patients Best Suited to PFO Closure Yael L. Maxwell December 17, 2018
News Conference News WCC 2018 CVD, Other Noncommunicable Diseases Hit Lower-Income Countries With Heavy Financial Burden Todd Neale December 06, 2018
News Conference News WCC 2018 WHF Celebrates 40th Anniversary as World Congress Kicks Off in Dubai Todd Neale December 05, 2018
News Daily News SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients Michael O'Riordan December 04, 2018
News Daily News Healthy Behaviors Linked to Lower Risk of Subclinical Atherosclerosis in Middle-aged Women Yael L. Maxwell November 30, 2018
News Daily News Women With Acute MI Less Likely to Survive or Receive Guideline-Recommended Care L.A. McKeown November 29, 2018
News Daily News Are the Best Hospitals Actually the Best? Analysis Looks at US News & World Report Rankings Yael L. Maxwell November 28, 2018
News Daily News Certain Risk Factors Carry Higher MI Risk in Women Than in Men Shelley Wood November 23, 2018
News Daily News Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts Michael O'Riordan November 23, 2018
News Daily News Female Cardiologists and Interventionalists Rare, Isolated in Australia and New Zealand Shelley Wood November 22, 2018
News Conference News AHA 2018 Greater Need for Cooperative Care in Women’s Heart Health, Two Studies Suggest Yael L. Maxwell November 16, 2018
News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018
News Opinion Conversations in Cardiology Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC? November 16, 2018
News Daily News ‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People Caitlin E. Cox November 15, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News AHA 2018 Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI Michael O'Riordan November 14, 2018
News Conference News AHA 2018 Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis Caitlin E. Cox November 13, 2018